BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8237924)

  • 1. High-grade dysplasia in Barrett's esophagus: an evolving clinical dilemma.
    Sampliner RE
    Am J Gastroenterol; 1993 Nov; 88(11):1811-2. PubMed ID: 8237924
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgical management of high-grade dysplasia in Barrett's esophagus.
    Rice TW; Falk GW; Achkar E; Petras RE
    Am J Gastroenterol; 1993 Nov; 88(11):1832-6. PubMed ID: 8237928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
    Cameron AJ; Carpenter HA
    Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.
    Skacel M; Petras RE; Gramlich TL; Sigel JE; Richter JE; Goldblum JR
    Am J Gastroenterol; 2000 Dec; 95(12):3383-7. PubMed ID: 11151865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in Barrett's esophagus: management of high grade dysplasia.
    Sharma P
    Semin Gastrointest Dis; 2001 Jan; 12(1):26-32. PubMed ID: 11215852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's esophagus.
    Byrd D; McKinley MJ; Floch MH; Nair S
    Gastroenterologist; 1994 Jun; 2(2):160-5. PubMed ID: 8055240
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
    Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
    Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation.
    Byrne JP; Armstrong GR; Attwood SE
    Am J Gastroenterol; 1998 Oct; 93(10):1810-5. PubMed ID: 9772036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies.
    Downs-Kelly E; Mendelin JE; Bennett AE; Castilla E; Henricks WH; Schoenfield L; Skacel M; Yerian L; Rice TW; Rybicki LA; Bronner MP; Goldblum JR
    Am J Gastroenterol; 2008 Sep; 103(9):2333-40; quiz 2341. PubMed ID: 18671819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe dysplasia in Barrett's esophagus].
    Penna Ch
    J Chir (Paris); 2002 Oct; 139(5):289-92. PubMed ID: 12410131
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.
    Vieth M; Schubert B; Lang-Schwarz K; Stolte M
    Endoscopy; 2006 Dec; 38(12):1201-5. PubMed ID: 17163319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.